RxDoctor Payments Data

Kapil Dua, DPM

Podiatrist · Kansas City, KSNPI 1114176765

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $488 and has fallen 53.5% since, to $227 in 2025.

$1,622in general payments, 2019–2025

Across 96 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$214
  • Smith+Nephew$179
  • Paratek Pharmaceuticals, Inc.$167
  • Nevro Corp.$146
  • Melinta Therapeutics, LLC$126
  • AbbVie$107
  • plus $683 from 19 others

What the payments were for

  • Food & beverage$1,622100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,622 in reported general payments places this provider in the 60th percentile of 30 podiatrist providers in Kansas.

See all podiatrist providers in Kansas

Medicare billing

Part B allowed, 2024
$104,310
Medicare patients
469
Services billed
2,135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox53$2,281
Econazole Nitrate36$746
Mupirocin60$580
Ammonium Lactate49$483
Doxycycline Hyclate37$321
Clotrimazole11$175
Clindamycin Hcl18$91

Paid to pharmacies, not to this prescriber.

Other podiatrist in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →